Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Rat CXCL3/GRO gamma/CINC-2/DCIP-1 Biotinylated Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems BAF516
This item is not returnable.
View return policy
Description
CXCL3/GRO gamma/CINC-2/DCIP-1 Polyclonal specifically detects CXCL3/GRO gamma/CINC-2/DCIP-1 in Rat samples. It is validated for Western Blot, ELISA Detection (Matched Antibody Pair).Specifications
CXCL3/GRO gamma/CINC-2/DCIP-1 | |
Polyclonal | |
Biotin | |
Q10746 | |
Cxcl3 | |
E. coli-derived recombinant rat CXCL3/CINC-2 alpha/beta Arg33-Ser100 Accession # Q10746 | |
50 μg | |
Primary | |
Detects rat CXCL3/CINC-2 alpha/beta in ELISAs and Western blots. In sandwich immunoassays, approximately 30% cross-reactivity with recombinant rat (rr) CINC-3 is observed and less than 0.1% cross-reactivity with rrCINC-1, recombinant mouse (rm) KC, rmMIP-2, and recombinant human GRO alpha is observed. | |
Rat | |
IgG |
Western Blot, ELISA | |
LYOPH | |
Western Blot 0.1 ug/mL, ELISA Detection (Matched Antibody Pair) 0.1-0.4 ug/mL | |
chemokine (C-X-C motif) ligand 3, CINC-2, CINC-2b, C-X-C motif chemokine 3, Dcip1, Gm1960, GRO gamma, GRO3, GRO3 oncogene, GROg, GRO-gamma, GRO-gamma(1-73), Growth-regulated protein gamma, Macrophage inflammatory protein 2-beta, melanoma growth stimulatory activity gamma, MGSA gamma, MIP-2b, MIP2B, MIP2-beta, SCYB3 | |
Goat | |
Affinity Purified | |
RUO | |
2921 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction